Reaching the last 20%: a targeted HIV self-test secondary distribution intervention to engage high-risk men in Kenya

达到%20the%20last%2020%:%20a%20针对性%20HIV%20自检%20次要%20分布%20干预%20至%20参与%20高风险%20男性%20in%20肯尼亚

基本信息

  • 批准号:
    10480476
  • 负责人:
  • 金额:
    $ 66.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-06 至 2027-04-30
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Limited use of HIV services by those at highest risk is one of the primary reasons for continued HIV transmission in sub-Saharan Africa. Identifying and engaging these individuals—particularly the 20% of people living with HIV who are unaware of their status—is a major challenge that is not being met by existing service delivery approaches. Men who purchase sex (MPS) are of particularly high priority because they are twice as likely to be HIV-infected as other men and are inherently challenging to identify and reach with HIV services. The proposed project will take place in the region of Kenya with the highest HIV prevalence and seeks to promote engagement in HIV testing, prevention, and care by MPS. Preliminary data demonstrate that “secondary distribution” of HIV self-tests by women who sell sex (WSS) to their sexual partners is acceptable, feasible, and safe and leads to high male partner testing. However, the use of post–self-test services has seldom been promoted or measured in a secondary distribution model. Our interdisciplinary and experienced team of Investigators will address this key gap. Led by an Early Stage Investigator, this project will use a pair-matched cluster-randomized trial design to test an innovative, well-targeted HIV self-test secondary distribution intervention to promote uptake of HIV services by MPS. Clusters served by Ministry of Health–supported HIV clinics will be randomized to receive the secondary distribution intervention or standard of care. In intervention clusters, we will recruit WSS from key population clinics and transactional sex “hot spots.” WSS will be provided with oral fluid–based HIV self-tests and encouraged to distribute them to their male transactional sex partners. Self-test kits will include salient information for men on clinic location and hours within their cluster, and pilot-tested messaging on the importance of early ART initiation, and the availability and benefits of PrEP. In Aim 1, we will evaluate programmatic data from HIV clinics in study clusters to objectively determine the intervention’s impact on uptake of confirmatory testing, ART initiation, and PrEP initiation by men. In Aim 2, we will conduct a process evaluation to characterize factors influencing intervention effectiveness. We will assess secondary distribution patterns and characterize the MPS population receiving self-tests through quantitative program data and a follow-up questionnaire among enrolled WSS. We will use qualitative data obtained through in-depth interviews with MPS to explore pathways and contextual factors influencing whether they accessed post-test services. In Aim 3, we will compute the incremental cost-effectiveness of our intervention to inform decisions about broader implementation. This project has the potential to break new ground on ways to engage high-risk and hard-to- reach populations in HIV services. If effective, our approach could be readily adapted to other settings and help advance global goals for HIV elimination.
项目摘要 高危人群对艾滋病毒服务的利用有限,是艾滋病毒持续传播的主要原因之一。 在撒哈拉以南非洲地区传播。识别和吸引这些人,特别是20%的人, 艾滋病毒感染者不知道自己的状况,这是现有服务无法应对的一个重大挑战 交付方法。购买性服务的男性(MPS)尤其受到高度重视,因为他们是男性的两倍。 他们可能像其他男性一样感染艾滋病毒,在确定和提供艾滋病毒服务方面具有固有的挑战性。 拟议的项目将在艾滋病毒流行率最高的肯尼亚地区实施,并力求 促进公共卫生部参与艾滋病毒检测、预防和护理。初步数据显示, 向其性伴侣提供性服务的妇女进行艾滋病毒自我检测的“二次分发”是可以接受的, 可行的,安全的,并导致高男性伴侣测试。然而,使用后自检服务, 很少在二级分销模式中推广或衡量。我们的跨学科和经验丰富 研究人员团队将解决这一关键差距。 在早期研究者的领导下,该项目将使用配对的随机分组试验设计, 测试一种创新的、目标明确的艾滋病毒自我检测二级分发干预措施,以促进艾滋病毒的吸收 服务MPS由卫生部支助的艾滋病毒诊所服务的群组将随机接受 二次分配干预或护理标准。在干预集群中,我们将从关键的 人口诊所和性交易“热点”。将为WSS提供基于口服液的HIV自检 并鼓励他们将其分发给男性交易性伴侣。自检工具包将包括 为男性提供关于诊所位置和所在群组内时间的信息, 早期ART启动的重要性,以及PrEP的可用性和益处。在目标1中,我们将评估 研究组中艾滋病毒诊所的方案数据,以客观地确定干预措施对 男性接受确证性检测、ART启动和PrEP启动。在目标2中,我们将开展一项进程, 评估以确定影响干预效果的因素。我们将评估二次分配 模式和特征的MPS人口接受自我测试,通过定量程序数据和 在入组的WSS中进行随访问卷调查。我们将使用通过深入访谈获得的定性数据 与MPS探讨影响他们是否获得测试后服务的途径和背景因素。在 目标3,我们将计算我们的干预措施的增量成本效益,为更广泛的决策提供信息。 实施.该项目有可能在参与高风险和难以实现的 向艾滋病毒服务的人群提供服务。如果有效,我们的方法可以很容易地适应其他环境, 推动实现消除艾滋病毒的全球目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sue Napierala其他文献

Sue Napierala的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sue Napierala', 18)}}的其他基金

Reaching the last 20%: a targeted HIV self-test secondary distribution intervention to engage high-risk men in Kenya
达到%20the%20last%2020%:%20a%20针对性%20HIV%20自检%20次要%20分布%20干预%20至%20参与%20高风险%20男性%20in%20肯尼亚
  • 批准号:
    10636880
  • 财政年份:
    2022
  • 资助金额:
    $ 66.89万
  • 项目类别:
HIV Prevention among Young Female Sex Workers: an Implementation Research Approach
年轻女性性工作者的艾滋病毒预防:一种实施研究方法
  • 批准号:
    9272008
  • 财政年份:
    2016
  • 资助金额:
    $ 66.89万
  • 项目类别:
Assessing Acceptability and Feasibility of HIV Self-Testing and Linkage to HIV Services in Zimbabwe
评估津巴布韦艾滋病毒自我检测及其与艾滋病毒服务的联系的可接受性和可行性
  • 批准号:
    8730296
  • 财政年份:
    2014
  • 资助金额:
    $ 66.89万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 66.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了